Pine Tree Equity Recapitalizes Chemistry Rx

March 1, 2021

Pine Tree Equity IV, LP recapitalized Madame Rx, LLC d/b/a Chemistry Rx in March 2021, partnering with the founder and management team. The recapitalization will support Chemistry Rx’s geographic expansion and enable pursuit of complementary add-on acquisitions to grow the compounding and specialty pharmacy platform.

Buyers
Pine Tree Equity IV, LP (Pine Tree Equity)
Targets
Madame Rx, LLC d/b/a Chemistry Rx
Location
Pennsylvania, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.